| 000 | 01599 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517194111.0 | ||
| 264 | 0 | _c20190204 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1178-1661 | ||
| 024 | 7 |
_a10.1007/s40271-017-0291-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlmeida, Paulo H R F | |
| 245 | 0 | 0 |
_aQuality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications. _h[electronic resource] |
| 260 |
_bThe patient _c08 2018 |
||
| 300 |
_a377-389 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 | _aBlood Glucose |
| 650 | 0 | 4 | _aBrazil |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
| 650 | 0 | 4 | _aGlycated Hemoglobin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aInsulin Glargine _xadverse effects |
| 650 | 0 | 4 |
_aInsulin, Isophane _xadverse effects |
| 650 | 0 | 4 | _aPatient Satisfaction |
| 650 | 0 | 4 | _aQuality of Life |
| 700 | 1 | _aSilva, Thales B C | |
| 700 | 1 | _ade Assis Acurcio, Francisco | |
| 700 | 1 | _aGuerra Júnior, Augusto A | |
| 700 | 1 | _aAraújo, Vania E | |
| 700 | 1 | _aDiniz, Leonardo M | |
| 700 | 1 | _aGodman, Brian | |
| 700 | 1 | _aAlmeida, Alessandra M | |
| 700 | 1 | _aAlvares, Juliana | |
| 773 | 0 |
_tThe patient _gvol. 11 _gno. 4 _gp. 377-389 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40271-017-0291-3 _zAvailable from publisher's website |
| 999 |
_c27968569 _d27968569 |
||